SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-113744
Filing Date
2024-10-09
Accepted
2024-10-09 16:15:04
Documents
1
Period of Report
2024-10-04

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 5084
  Complete submission text file 0000950170-24-113744.txt   7800
Mailing Address 30 ROCKEFELLER PLAZA, SUITE 5508 NEW YORK NY 10112
Business Address
Hove Anders D (Reporting) CIK: 0001365618 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40315 | Film No.: 241362931

Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Issuer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 295 MADISON AVENUE 32ND FL NEW YORK NY 10017
Business Address 295 MADISON AVENUE 32ND FL NEW YORK NY 10017 917-940-2732
ACORN BIOVENTURES, L.P. (Reporting) CIK: 0001766853 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40315 | Film No.: 241362933

Mailing Address 420 LEXINGTON AVENUE SUITE 2626 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2626 NEW YORK NY 10170 212-299-4777
ACORN CAPITAL ADVISORS GP, LLC (Reporting) CIK: 0001813692 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40315 | Film No.: 241362932